Basophils inhibit proliferation of CD4+ T cells in autologous and allogeneic mixed lymphocyte reactions and limit disease activity in a murine model of graft versus host disease |
| |
| Authors: | Fabian J. Hermann Manuel Rodriguez Gomez Kristina Doser Matthias Edinger Petra Hoffmann Gabriela Schiechl Yvonne Talke Nicole Göbel Kathrin Schmidbauer Shahzad N. Syed Hilke Brühl Matthias Mack |
| |
| Affiliation: | 1. Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany;2. Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany;3. RCI Regensburg Centre for Interventional Immunology, Regensburg, Germany;4. Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany |
| |
| Abstract: | Basophils are known to modulate the phenotype of CD4+ T cells and to enhance T helper type 2 responses in vitro and in vivo. In this study, we demonstrate that murine basophils inhibit proliferation of CD4+ T cells in autologous and allogeneic mixed lymphocyte reactions. The inhibition is independent of Fas and MHC class II, but dependent on activation of basophils with subsequent release of interleukin‐4 (IL‐4) and IL‐6. The inhibitory effect of basophils on T‐cell proliferation can be blocked with antibodies against IL‐4 and IL‐6 and is absent in IL‐4/IL‐6 double‐deficient mice. In addition, we show that basophils and IL‐4 have beneficial effects on disease activity in a murine model of acute graft‐versus‐host disease (GvHD). When basophils were depleted with the antibody MAR‐1 before induction of GvHD, weight loss, GvHD score, mortality and plasma tumour necrosis factor levels were increased while injection of IL‐4 improved GvHD. Basophil‐depleted mice with GvHD also have increased numbers of CD4+ T cells in the mesenteric lymph nodes. Our data show for the first time that basophils suppress autologous and allogeneic CD4+ T‐cell proliferation in an IL‐4‐dependent manner. |
| |
| Keywords: | basophils CD4+ T cells graft‐versus‐host disease interleukin‐4 interleukin‐6 mixed lymphocyte reaction |
|
|
